Log In
Print this Print this

Prenatal Aneuploidy Test (Panorama)

  Manage Alerts
Collapse Summary General Information
Company Natera Inc.
DescriptionNon-invasive prenatal multiplex assay that detects fetal trisomies 13, 18 and 21 and sex chromosome abnormalities in maternal blood cell-free DNA (cfDNA)
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationGenetic disorders, Diagnostic
Indication DetailsDetect fetal chromosomal abnormalities in maternal blood; Detect microdeletion syndromes
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today